Scientific Programme Friday 20 September 2019

FRIDAY 20 SEPTEMBER
Room Red 1 Red 2 Blue 2 Yellow 2+3 Blue 1 
       

 

Scientific Committee meeting -
meeting room 2 
07.00-08.00
Time/Society  ESVC ESCG abstracts

ESVIM/ISCAID

ESVONC Education stream
 08.00-09.00

ECVIM-CA Cardiology Examination Info Session

 Purina Institute breakfast session
07.45-08.45 

ECVIM-CA Oral Exam Demonstration for Internal Medicine Residents and Advisors

Boehringer Ingelheim breakfast session 
07.45-08.45 

Anne French (GB)
Impact of veterinary corporations on the profession

09.00-09.40

 

Brian Scansen (US)
Advanced diagnostic imaging of the right ventricle

 Jonathan Mochel (US)
Reconciling Quantitative and Clinical Sciences in VetMed 2.0.

 

Lars Korn (D)
Vaccine acceptance in human medicine and its influencing factors?

Ambra Morisi (GB)
Machine learning in digital pathology to improve cancer diagnosis in humans and animals

Penny Watson (GB)
Communications training in the undergraduate and post-graduate curriculum: does it really make a difference?

09.45-10.25

Michele Borgarelli and DELAY investigators (US)
DELAY of appearance of symptoms of canine degenerative mitral valve disease treated with Spironolactone and Benazepril (the DELAY study)


09.45-10.00
Ruggerone
ESCG-O-1
10.00-10.15 
Stavroulaki
ESCG-O-2
10.15-10.30
Bermudez Sanchez
ESCG-O-3
 Lars Korn (D)
Mandates VS behavioural insights to increase vaccine uptake

Jonathan Bray (GB)
Pre-operative interrogation of tumours to improve local control

Sebastian Berger (CH)
Cooperation and conflict: Lessons from behavioral science

10.30-11.15

COFFEE BREAK – EXHIBITION

11.20-12.00

11.20-11.35
Menciotti
ESVC-O-4
11.35-11.50 
Ksiazek
ESVC-O-5
11.50-12.05
Claretti
ESVC-O-6

11.20-11.35
Swales
ESCG-O-4
11.35-11.50
Petrelli
ESCG-O-5 
11.50-12.05
Moberg
ESCG-O-6

Zoe Belshaw (GB)
Perspective of pet owners on preventative medicine and vaccination

Paul Huang (GB)
Precision medicine in sarcomas

Sebastian Berger (CH)

Dealing with conflict - practical exercises/group work o.ä 

12.05-12.45

12.05-12.20
Adin
ESVC-O-7
12.20-12.35
Culshaw
ESVC-O-8
12.35-12.50
Spalla
ESVC-O-9

12.05-12.20
Ziese
ESCG-O-7
12.20-12.35
Kaufmann
ESCG-O-8
 Uwe Truyen (D)
Duration of vaccine-induced immunity

Alex Lee (GB)
The immune microenvironment as biomarker and therapeutic target in soft tissue sarcomas in humans

 Sebastian Berger (CH)

Debriefing session

12.50-14.20

LUNCH BREAK – EXHIBITION

13.20-14.15
ESVC AGM  ESCG AGM ESVIM AGM Oncology Diplomate meeting   
      
Time/Society  ESVC abstracts  ESCG 

 ESVIM/ISCAID

ESVONC abstracts   Education stream
14.25-15.05

14.25-14.40
van Hoek
ESVC-O-10
14.40-14.55
Patata
ESVC-O-11
14.55-15.10
Hanas
ESVC-O-12

Kristen Messenger (US)
NSAID-induced GI injury: Mechanisms and novel modulators of inflammation and repair

Katrin Hartmann (D)
Titre testing instead of routine vaccination
14.25-14.40
Aupperle-Lellbach
ESVONC-O-1
14.40-14.55 
Kleiter
ESVONC-O-2
14.55-15.10
Borgatti
ESVONC-O-3
Resident masterclass

Loic Desquilbet (F)

Basics of statistical analysis and study design for comparative studies
15.10-15.50

15.10-15.25 
Busato
ESVC-O-13
15.25-15.40
Ferasin
ESVC-O-14 

15.40-15.55
Giraud
ESVC-O-15

Katie Tolbert (US)
Using acid suppressants effectively

Vanessa Barrs (AUS)
Herd immunity and risk of outbreaks

15.10-15.25 
Skor
ESVONC-O-4
15.25-15.40 
Rigas
ESVONC-O-5
15.40-15.55 
Willcox
ESVONC-O-6

15.55-16.25

COFFEE BREAK - EXHIBITION 

16.30-17.10

16.30-16.45 
Bourguignon
ESVC-O-16
16.45-17.00
Greet
ESVC-O-17
17.00-17.15
Perego
ESVC-O-18

Katie Tolbert (US)
Approach to GI bleeding: Thinking beyond acid suppression

16.30-16.45 
Hirt
ESVIM-O-1
16.45-17.00 
Fastrès
ESVIM-O-2
17.00-17.15 
Grobman
ESVIM-O-3

16.30-16.45 
Skor
ESVONC-O-7
16.45-17.00 
Willcox
ESVONC-O-8
17.00-17.15  
Fournier 
ESVONC-O-9

Resident masterclass

Loic Desquilbet (F)

Basics of statistical analysis and study design for comparative studies

Continued

 

 
17.15-17.55

17.15-17.30 
Perego
ESVC-O-19
17.30-17.45
Costa
ESVC-O-20 

17.45-18.00
Franchini
ESVC-O-21

Karin Allenspach (US)
Use of intestinal organoids to improve predictability of bioavailability and GI side effects in oral veterinary drugs

17.15-17.30 
Jaffey
ESVIM-O-4
17.30-17.45
Jaffey
ESVIM-O-5 

17.45-18.00
Jaffey
ESVIM-O-6
17.15-17.30 
Fournier
ESVONC-O-10
17.30-17.45 
Ossowska
ESVONC-O-11
17.45-18.00
Wood
ESVONC-O-12
18.00-18.30      Meet the Executive ECVIM-CA       

19.30 - 01.30 

 CONGRESS EVENING AND DANCE PARTY